Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.05 is 15% below its 5-year average of 1.24, near the low end of its 5-year range (0.98–2.73).
As of the fiscal period ended Tuesday, June 30, 2026. 3.03% above its 12-month average of 1.02.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.05.
CURRENT RATIO
1.05
CURRENT RATIO AVG TTM
1.02
CURRENT RATIO AVG 3Y
1.25
CURRENT RATIO AVG 5Y
1.24
CURRENT RATIO AVG 10Y
1.03
CURRENT RATIO AVG 15Y
0.85
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.03%
CURRENT VS 3Y AVG
-15.50%
CURRENT VS 5Y AVG
-15.25%
CURRENT VS 10Y AVG
+2.19%
CURRENT VS 15Y AVG
+23.91%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-71.94%
vs the sector median at left
Market Cap
$17.99M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$17.01M
Current Ratio
6.03
TTM Avg
7.38
3Y Avg
5.62
5Y Avg
4.97
Market Cap
$16.74M
Current Ratio
4.61
TTM Avg
2.49
3Y Avg
1.77
5Y Avg
2.58
Market Cap
$16.76M
Current Ratio
3.37
TTM Avg
8.28
3Y Avg
7.56
5Y Avg
6.68
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cosmos Health Inc. (COSM) | $17.68M | 1.05 | 1.02 | 1.25 | 1.24 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.20 | 0.34 | 6.34 | 6.11 |
| PAVmed Inc. (PAVM)vs › | $17.23M | 1.19 | 0.12 | 0.44 | 2.27 |
| Lipocine Inc. (LPCN)vs › | $17.11M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 6.03 | 7.38 | 5.62 | 4.97 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | 2.48 | 1.52 | 2.21 | 4.42 |
| P3 Health Partners Inc. (PIII)vs › | $18.61M | 0.46 | 0.30 | 0.39 | 0.60 |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | 4.61 | 2.49 | 1.77 | 2.58 |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.76M | 3.37 | 8.28 | 7.56 | 6.68 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.70M | 27.85 | 15.71 | 9.25 | 10.43 |
Current Ratio
1.05
Quick Ratio
0.92
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.05 |
| 2026-03-31 | 1.08 |
| 2025-12-31 | 1.00 |
| 2025-09-30 | 0.99 |
| 2025-06-30 | 0.98 |
| 2025-03-31 | 1.05 |
| 2024-12-31 | 0.99 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 1.35 |
| 2024-03-31 | 1.46 |
| 2023-12-31 | 1.51 |
| 2023-09-30 | 2.06 |
| 2023-06-30 | 2.19 |
| 2023-03-31 | 2.73 |
| 2022-12-31 | 2.58 |
| 2022-09-30 | 1.05 |
| 2022-06-30 | 1.12 |
| 2022-03-31 | 1.40 |
| 2021-12-31 | 1.33 |
| 2021-09-30 | 1.18 |
| 2021-06-30 | 1.33 |
| 2021-03-31 | 1.21 |
| 2020-12-31 | 1.19 |
| 2020-09-30 | 0.87 |
| 2020-06-30 | 0.84 |
| 2020-03-31 | 0.73 |
| 2019-12-31 | 0.75 |
| 2019-09-30 | 0.73 |
| 2019-06-30 | 0.78 |
| 2019-03-31 | 0.83 |
| 2018-12-31 | 0.82 |
| 2018-09-30 | 1.31 |
| 2018-06-30 | 0.84 |
| 2018-03-31 | 0.68 |
| 2017-12-31 | 0.69 |
| 2017-09-30 | 0.74 |
| 2017-06-30 | 0.67 |
| 2017-03-31 | 0.56 |
| 2016-12-31 | 0.54 |
| 2016-09-30 | 0.53 |
| 2016-06-30 | 0.33 |
| 2016-03-31 | 0.32 |
| 2015-12-31 | 0.29 |
| 2015-09-30 | 3.85 |
| 2015-06-30 | 3.95 |
| 2015-03-31 | 4.06 |
| 2014-12-31 | 4.10 |
| 2014-09-30 | 4.73 |
| 2014-06-30 | 3.10 |
| 2014-03-31 | 2.05 |
| 2013-12-31 | 0.94 |
| 2013-09-30 | 0.36 |
| 2013-07-31 | 0.05 |
| 2013-04-30 | 0.02 |
| 2013-01-31 | 0.00 |
| 2012-10-31 | 0.00 |
| 2012-07-31 | 0.00 |
| 2012-04-30 | 0.01 |
| 2012-01-31 | 0.00 |
| 2011-10-31 | 0.05 |
| 2011-07-31 | 0.76 |
| 2011-04-30 | 12.29 |
| 2011-01-31 | 11.72 |
| 2010-10-31 | 0.04 |
| 2010-07-31 | 0.03 |
| 2010-04-30 | 0.55 |
| 2010-01-31 | 0.87 |
| 2009-10-31 | 0.00 |
